|
|
Study about Dapoxetine demonstrates intercourse satisfaction
Men taking dapoxetine hydrochloride for the treatment of premature ejaculation (PE) experienced
significant improvements in sexual function, including ejaculatory control, satisfaction with
sexual intercourse for both the men and their partners, and increases in intravaginal ejaculatory
latency time (IELT), according to a new study.
The test involved 2,614 men aged between 18 and 77, who maintained monogamous sexual relationships
of more than six months and suffered from premature ejaculation.
Each premature ejaculation subject received 30 milligrams or 60 milligrams of dapoxetine over 12 weeks in two identical
placebo-controlled trials.
The results showed the drug helped them lengthen intercourse three to four times. What's more,
dapoxetine increased their staying power with the first dose and helped maintain the increases
over the whole study period.
Study reported intercourse satisfaction
The percentage of study participants rating their control over ejaculation as "fair to very good"
increased from 2.5 percent to nearly 52 percent for those taking 30-milligram doses of dapoxetine.
For those taking 60 milligrams, it shot up from 3.3 percent to more than 58 percent, the trials showed.
The share of pill takers calling their satisfaction from intercourse "good to very good"
almost doubled, as did the satisfaction of their female partners.
The most common adverse side effect reported with both doses were nausea and headache.
Doctor Jon Pryor, chief urologist at the University of Minnesota and lead researcher said:
"They demonstrate that, for the first time, a medicine can be taken by men on an on-demand basis
and provide significant improvement in their premature ejaculation condition."
NOTE:
The Information on this site is provided for information only,
and is not meant to substitute for the advice of your own physician or other medical professional.
| |
